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Methamphetamine Induces Striatal Cell Death Followed by the Generation
of New Cells and a Second Round of Cell Death in Mice
I. K. Tulloch, L. Afanador, J. Zhu and J. A. Angulo*
Hunter College of the City University of New York, Department of Biological Sciences, New York NY, USA
Abstract: Our laboratory has been investigating the impact of a neurotoxic exposure to methamphetamine (METH) on
cellular components of the striatum post-synaptic to the dopaminergic terminals. A systemic bolus injection of METH (30
mg/kg, ip) induces the production of new cells in the striatum during a period lasting from 24-48 hours after METH. The
newly generated cells arise from dormant striatal progenitors and not from the subventricular zone. The newly generated
cells display glial phenotypes and begin to die 24 hours after birth, or 2.5 days post-METH. The protracted phase of cell
death lasts for at least three months post-METH at which time the bulk of the newly generated cells have disappeared. The
METH-induced production of new cells is associated with enlarged striatal volume (up to 50% larger than controls
in some animals). As the newly generated cells die over a period of three months, the enlarged striatal volume normalizes.
In conclusion, a neurotoxic dose of METH induces the generation of new cells in the striatum associated with enlarged
striatal volume. The new cells die over three months post-METH and the enlarged striatal volume returns to control levels.
This observation is significant because studies involving METH users show striatal enlargement and the normalization of
striatal volume in METH users who have been abstinent for up to 20 months.
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INTRODUCTION
Methamphetamine (METH) is an illicit drug that has
been increasing in popularity for recreational use and
according to recent estimates has become the second most
abused drug after marijuana [1]. The illicit use of METH is a
great burden on society because METH use is associated
with aggressive behavior that is a major problem for law
enforcement [2, 3]. Recent studies demonstrate that acute
and chronic METH use induces neurotoxic responses in the
human brain that can further deteriorate into neural damage
including structural abnormalities. For example, studies utilizing positron emission tomography showed decreased levels
of dopamine transporter [4, 5] and serotonin transporter sites
[6] in various brain regions including the caudate and putamen. Detoxified METH users showed increased glucose
metabolism (an index of brain function) in parietal brain
regions but decreased glucose utilization in the striatum and
thalamus [7]. Magnetic resonance imaging studies demonstrated that the brains of METH users display significant
deficits in gray-matter in the cingulated, limbic and paralimbic cortices suggesting the loss of neurons [8]. A separate
study demonstrated the enlargement of the caudate nucleus,
globus pallidus and putamen, nucleus accumbens and the
parietal cortex of adult METH users [9, 10].
The mechanism of action of METH has been studied
extensively in animal model species such as the rodent. In
the rodent brain, METH induces long-term depletion of dopamine transporters and tyrosine hydroxylase in striatal
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dopaminergic terminals [11, 12], depletion of tryptophan hydroxylase in serotonergic terminals [13], and degeneration of
neural tissue in the striatum [14]. In addition to deficits in
pre-synaptic dopaminergic terminals of the striatum, METH
induces the loss of neurons in various brain regions such as
the cortex and striatum [15-17]. In the present study, we
have investigated the METH-induced loss of striatal neurons
over a period of three months. METH induces rapid cell loss
(24 hours) followed by the generation of new cells that die
over a period of three months. The increased number of new
cells is associated with enlargement of the striatum that normalizes over a period of three months post-METH.
MATERIALS AND METHODS
Animals
Male ICR mice (Taconic, Germantown, NY) between 10
to 13 weeks of age were housed individually on a 12-h
light/dark cycle with food and water available ad libitum.
The mice were habituated for two weeks prior to commencement of intraperitoneal (i.p.) drug administration. All
procedures regarding animal use were performed in accordance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and were approved by
the Institutional Animal Care and Use Committee at Hunter
College of the City University of New York.
Drug Preparation and Treatment
(+)-Methamphetamine hydrochloride (Sigma, St. Louis,
MO) was dissolved in 10 mM phosphate-buffered saline, pH
7.4 (PBS) and injected i.p. at a dose of 30 mg/kg of body
weight in a volume of 200 μL. 5-Bromo-2’-deoxyuridine
(Sigma, St. Louis, MO) was dissolved in water and injected
at a dose of 100 mg/kg (i.p.).
©2011 Bentham Science Publishers Ltd.
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Proliferation
After two weeks of habituation, male ICR mice were
injected with 30 mg/kg METH or saline vehicle (i.p). After
METH, different groups of animals were injected with 100
mg/kg of bromo-deoxyuridine at the following times: 2, 24,
36 hours, 2, 3, 4, 5, 6, 7, 14 and 21 days. To allow for a
complete round of mitotic cell division, animals were sacrificed 24 hours after the bromo-deoxyuridine injection. They
were anesthetized with a mixture of 100mg/kg ketamine + 3
mg/kg acepromazine, then perfused with PBS, followed by
4% paraformaldehyde in PBS. Following perfusion, the
brains were removed from the skull and post-fixed in 4 %
paraformaldehyde overnight at 4oC, then cryo-protected in
30% sucrose in PBS solution for 24 hours at 4oC. After cryoprotection, the brains were stored at 80oC until used.
Apoptosis of Newly Generated Cells
49 Male ICR mice received a single METH injection
(30mg/kg, i.p.) followed by a single 100mg/kg injection of
bromo-deoxyuridine at 1.5 days post-METH. In order to
quantify the percentage of the new cells displaying pyknotic
nuclei, seven animals were randomly sacrificed and the tissue collected within five hours after the bromodeoxyuridine
injection. Total bromodeoxyuridine incorporation into nuclei
from these animals was used as baseline for comparison. The
other animals were randomly sacrificed at the following
post-METH time points: 2 days, 1, 2, 4, 8 or 12 weeks. Tissue was collected and processed in the same manner as in the
proliferation study above.
Immunohistochemistry
Coronal sections from one hemisphere were cut at 40 μm
thickness and serially collected from the striatum between
bregma 0.02 and 1.4 mm [18]. Six sections per animal were
processed using the free-floating method. Fluorescent immunostaining was visualized and quantified as follows: PBS
wash, followed by incubation at 65oC in a solution of 1:1
formamide and 0.375M sodium chloride/0.0375M sodium
citrate (pH 7) for two hours, then incubation in 2N HCL at
37oC for 30 minutes. After a 10-minute rinse in 0.1M boric
acid (pH 8.5), non-specific binding sites were blocked with
5% donkey serum in 0.2% Triton X100 in PBS at room temperature for one hour. Sections were then incubated in primary antibody, sheep anti-bromo-deoxyuridine immunoglobulin (1:500; Novus Biologicals, Littleton, CO) in 1%
donkey serum overnight at 4oC. After two PBS washes (five
minutes each), the sections were incubated for one hour in
secondary antibody, donkey anti-sheep conjugated to FITC
(1:500; Novus Biologicals, Littleton, CO) at room temperature. After two washes in PBS (five minutes each), the sections were mounted onto superfrost glass slides, sealed and
coverslipped with Vectorshield hard setTM mounting medium
for fluorescence (Vector Laboratories, Burlingame CA).
Quantification and Statistical Analysis
For the proliferation study, data from eight METH and
five control animals from each time point were analyzed. For
the apoptosis study, seven animals per survival time point
were analyzed. Each tissue sample was counted by two different individuals blind to the treatment condition to ensure a
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minimum 95% correlation in criteria. Proliferating cells were
defined as bromo-deoxyuridine-positive nuclei that morphologically appeared to have divided. (see Fig. 1C). Apoptosis
was defined as intensely stained bromo-deoxyuridinepositive round or crescent shaped clumps of compact nuclei
indicative of karyopyknosis.
Mean number of nuclei and striatal volumes were quantified using unbiased stereology powered by StereologerTM
software/hardware system from Stereology Resource Center
(Chester, MD), connected to a Leica DM 2500 microscope
from Leica Microsystems Inc. (Wetzlar, Germany) and a
MAC-pro computer system. A cross section of the striatum
was outlined at 5X magnification for each tissue sample (see
Fig. 1A). Stereologer’s dissector probe was used for counting and calculating the mean number of nuclei meeting mitotic or pyknotic criteria that fell within the inclusion lines of
the optical dissector at 100X magnification. Guard volume
was taken as the first and last two micrometers of tissue in
cross section. Cells within the guard volume were excluded
from the analysis. Statistical analysis was done using Prism
software (GraphPad inc. La Jolla, CA). For proliferation, a
two-way ANOVA was done to compare mean bromodeoxyuridine-positive nuclei for each treatment condition at
each time point. Post-hoc analysis included Bonferroni multiple comparisons test of significant differences. For pyknosis, the percent difference of bromo-deoxyuridine-positive
nuclei at 1.5 days post-METH and bromo-deoxyuridinepositive nuclei that were pyknotic at each time point was
calculated and a one-way ANOVA with Dunnet’s multiple
comparisons test of differences between 1.5 days postMETH and each of the other time points. The same type of
analysis was performed for striatal volume except that the
percent difference for each post-METH time point was calculated and compared to saline controls at 1.5 days.
RESULTS
In previous studies we showed that METH (30 mg/kg, ip)
induced the apoptosis of approximately 25% of striatal neurons 24 hours after a single bolus injection [17, 19]. In order
to investigate the possibility of production of new cells in the
aftermath of the striatal cell loss induced by METH, we injected mice (n=8 per group) with METH (30 mg/kg, i.p.)
followed by an injection of bromo-deoxyuridine (100 mg/kg,
i.p.) at various times after METH. Bromo-deoxyuridine is a
DNA precursor that becomes incorporated into nascent DNA
chains in place of thymidine during DNA replication prior to
mitotic division. The cells labeled with bromo-deoxyuridine
(new cells) can be reliably and conveniently visualized with
immunohistochemical methods. Fig. (1) shows the emergence of many new cells throughout the striatum at 36 hours
after METH (Fig. (1B)). Control animals injected with saline
display bromo-deoxyuridine-positive cells only in the subventricular zone (Fig. (1A)), an area of the adult brain that
supports neurogenesis. The new cells shown in Fig. (1B) do
not migrate to the striatum from the subventricular zone. We
base this hypothesis on the observation that pairs of newly
divided daughter cells can be found throughout all aspects of
the striatum (Fig. (1C)).
In order to determine the time(s) after METH when new
cells are generated in the striatum, we gave mice bromo-
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deoxyuridine at various times after METH. In Fig. (2) is
shown a time course of bromo-deoxyuridine-positive nuclei
at various times after a bolus injection of METH. There is a
narrow window between 24 and 48 hours after METH when
new cells emerge throughout the striatum (Fig. (2)). The
newly generated cells are not stable and begin to disappear at
2.5 days after METH, or 24 hours after birth (Fig. (3)). The
bulk of the newly generated cells die by a mechanism of
apoptosis displaying pyknotic morphology in their nuclei
(data not shown). The new cells continue to die for a period
of 12 weeks at which time the majority of the cells (approximately 60%) have disappeared (Fig. (3)). At the time
when the new cells appear and for most of the 12-week period of protracted cell death the striatum displays an enlargement due to an increase in volume as determined by
automated unbiased stereology (Fig. (4)). The enlargement
of the striatum is largest at one week post-METH because
two animals displayed abnormally large striata relative to
controls (Fig. (4)). The percent increases at 2.5 days and 2 and 4
weeks after METH in Fig. (4) did not approach statistical
significance at the 95% confidence level. Interestingly, the
enlarged striatal morphology normalizes over time (Fig. (4)).
DISCUSSION
The results presented in this study demonstrate that exposure to a single high dose of METH induces the production
of new cells (cytogenesis) in the striatum of mice at 24-48

Current Neuropharmacology, 2011, Vol. 9, No. 1

81

Fig. (2). Time course of incorporation of bromo-deoxyuridine into
new cells of the striatum after treatment with METH (0 time point).
Mice (n=8) were injected with METH (30 mg/kg, i.p.) and were
given an injection of bromo-deoxyuridine (100 mg/kg, i.p.) at the
times indicated under the x-axis. Sections of striatal tissue were
processed for immunohistochemistry with an antibody against
bromo-deoxyuridine. Cells were counted throughout the striatum by
automated unbiased stereology. Note the 24-hour window between
24 and 48 hours in which robust proliferation of cells occurs in the
striatum after METH treatment. Data were analyzed by two-way
ANOVA for comparison between the mean number of nuclei with
bromo-deoxyuridine incorporation per condition per time point.
***p<0.0001.

Fig. (1). METH induces the generation of new cells in the striatum. Male mice (n=8) were given METH (30 mg/kg, i.p.) followed by bromodeoxyuridine (100 mg/kg, i.p.) 36 hours after METH. New cells were visualized by immunostaining with an antibody against bromodeoxyuridine. There was no bromo-deoxyuridine incorporation in the striatum of mice treated with saline (A), however, several bromodeoxyuridine-positive cells (B) are visible throughout all aspects of the striatum. Note at high magnification (100x) the presence of daughter
cells that appear to have completed mitotic division (C). Bromo-deoxyuridine incorporation is visible in the subventricular zone (SVZ) because this area supports neurogenesis in the adult brain. CC, corpus callosum.
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some striatal neurons using TUNEL [15] or Fluoro-Jade C
[20]. The protracted phase of striatal cell death induced by
METH is restricted to the newly generated cells most of
which express the phenotype of glial cells (data not shown).
Work in progress in this laboratory is characterizing the phenotype and survival of the newly generated cells in the aftermath of METH.

Fig. (3). The majority of the newly generated cells die over a threemonth period by apoptosis. Mice were treated as in Fig. (2) above
and the number of pyknotic nuclei (apoptosis) were counted at
various times using unbiased stereology starting at 2.5 days after
METH. Pyknotic nuclei with bromo-deoxyuridine immunostaining
were counted throughout the striatum. Note that the some newly
generated cells display the pyknotic phenotype 24 hours after birth,
or 2.5 days after METH (bromo-deoxyuridine was injected 1.5 days
post-METH). One-way ANOVA showed significant differences
between the percent of bromo-deoxyuridine-positive nuclei with
pyknotic morphology at various time points after METH in comparison to the 1.5 days time point. ***P<0.0001.

Our results demonstrate that the production of new cells
is associated with enlarged striatal morphology. This observation is particularly significant in the light of recent studies
showing enlarged striatal volumes in METH users [9, 10,
21]. One study reported that subjects with enlarged putamen
and globus pallidus had relatively normal cognitive performance compared to subjects with smaller striatal structures
suggesting a compensatory response [9]. Our data demonstrate that the enlarged striatal volume normalizes over a
period of three months in mice, the same amount of time
associated with the bulk of the protracted cell death (see
Figs. 3 & 4). The human study that found enlarged striatal
volumes [9] involved METH users. However, a study assessing abstinent METH users drug-free for approximately two
years reported normal striatal volumes [22]. Our results show
that the mouse striatum normalizes over a period of three
months as most of the newly generated cells die by apoptosis, suggesting that the enlarged striatal volumes observed in
METH users may be accounted for by inflammation and the
production of new cells.
In conclusion, a bolus high dose of METH induces the
genesis of cells in the striatum immediately following the
loss of striatal neurons. The production of new cells is associated with enlarged striatal volume that normalizes over a
period of three months as the new cells die by apoptosis. A
similar pattern of striatal enlargement has been reported with
human METH use and normalization after protracted abstinence. More work is needed to determine the role played by
the new cells in the aftermath of METH in the striatum.
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*p<0.05.

Special thanks are given to Ms. Ina Mexhitaj, Ms. Nane
Ghazaryan and Mr. Alexander Davidis for technical assistance. This work was supported by R01 DA020142 from
the National Institute on Drug Abuse to JAA. Support for
infrastructure came from the Research Centers in Minority
Institutions grant awarded to Hunter College by NCRR/NIH.
REFERENCES
[1]

hours after METH. The emergence of new cells is associated
with enlarged striatal volume. The newly generated cells are
unstable and begin to die from one day after birth up to three
months, a phase we refer to as protracted cell death. Most of
the newly generated cells die by an apoptotic mechanism
associated with pyknotic morphology of the nuclei. The protracted cell death induced by METH is different from the
initial phase of cell loss occurring within the first 24 hours
after METH. This initial phase involves the loss of approximately 25% of striatal neurons: projection neurons and parvalbumin and cholinergic interneurons. The somatostatin/
NPY/NOS interneurons are resistant to METH [19]. Other
laboratories have also reported the METH-induced loss of

[2]
[3]
[4]

[5]

United Nations Office on Drugs and Crime (UNODC). World Drug
Report 2007. Vienna, Austria: UNODC Research and Analysis
Section, 2007. Reference Available from: http://www.unodc.org/
pdf/research/wdr07/WDR_2007.pdf [Accessed on: 27th September,
2008].
Ellinwood, E.H., Jr. Assault and homicide associated with
amphetamine abuse. Am. J. Psychiatry, 1971, 127, 1170-1175.
Szuster, R.R. Methamphetamine in psychiatric emergencies.
Hawaii Med. J., 1990, 49, 389-391.
McCann, U.D., Wong, D.E., Yokoi, E., Villemagne, V., Dannals,
R.E., Ricaurte, G.A. Reduced striatal dopamine transporter density
in abstinent methamphetamine and methcathinone users: evidence
from positron emission tomography. J. Neurosci., 1998, 18, 84178422.
Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada,
H., Yoshikawa, E., Futatsubashi, B.A., Takei, N., Mori, N.
Methamphetamine-related psychiatric symptoms and reduced brain

Methamphetamine Induces Striatal Cell Death Followed by the Generation

[6]

[7]

[8]

[9]

[10]

[11]
[12]
[13]

dopamine transporters studied with PET. Am. J. Psychiatry, 2001,
158, 1206-1214.
Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K.,
Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y.,
Tsuchiya, K.J., Tsukada, H., Iyo, M., Mori, N. Brain serotonin
transporter density and aggression in abstinent methamphetamine
abusers. Arc. Gen. Psychiatry, 2006, 63, 90-100.
Volkow, N., Chang, L., Wang, G., Fowler, J., Leonido-Yee, M.,
Franceschi, D., Sedler, M.J., Gatley, S. J., Hitzemann, R., Ding, Y.-S.
Association of dopamine transporter reduction with psychomotor
impairment in methamphetamine abusers. Am. J. Psychiatry, 2001,
158, 377-382.
Thompson, P.M., Hayashi, K.M., Simon, S.L., Geaga, J.A., Hong,
M.S., Sui, Y., Lee, J.Y., Toga, A.W., Ling, W., London, E.D.
Structural abnormalities in the brains of human subjects who use
methamphetamine. J. Neurosci., 2004, 24, 6028-6036.
Chang, L., Cloak, C., Patterson, K., Grob, C., Miller, E.N., Ernst,
T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol. Psychiatry, 2005, 57, 967-974.
Jernigan, T.L., Gamst, A.C., Archibald, S.L., Fennema-Notestine,
C., Mindt, M.R., Marcotte, T.L., Heaton, R.K., Ellis, R. J., Grant, I.
Effects of methamphetamine dependence and HIV infection on
cerebral morphology. Am. J. Psychiatry, 2005, 162, 1461-1472.
Seiden, L.S., MacPhail, R.C., Oglesby, M.W. Catecholamines and
drug-behavior interactions. Fed. Proc., 1975, 34, 1823-1831.
Woolverton, W.L., Ricaurte, G.A., Forno, L.S., Seiden, L.S. Longterm effects of chronic methamphetamine administration in rhesus
monkeys. Brain Res., 1989, 486, 73-78.
Hanson, G.R., Gibb, J.W., Metzger, R.R., Kokoshka, J.M.,
Fleckenstein, A.E. Methamphetamine-induced rapid and reversible
reduction in the activities of tryptophan hydroxylase and dopamine
transporters: oxidative consequences. Ann. N.Y. Acad. Sci., 1998,
844, 103-107.

Received: October 01, 2009

Current Neuropharmacology, 2011, Vol. 9, No. 1
[14]

[15]

[16]

[17]

[18]
[19]
[20]

[21]

[22]

83

Ricaurte, G.A., Guillery, R.W., Seiden, L.S., Schuster, C.R.,
Moore, R.Y. Dopamine nerve terminal degeneration produced by
high doses of methylamphetamine in the rat brain. Brain Res.,
1982, 235, 93-103.
Deng, X., Wang, Y., Chou, J., Cadet, J.L. Methamphetamine
causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. Mol.
Brain Res., 2001, 93, 64-69.
Eisch, A.J., Marshall, J.F. Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical
cell body injury. Synapse, 1998, 30, 433-445.
Zhu, J.P.Q., Xu, W., Angulo, J.A. Disparity in the temporal
appearance of methamphetamine-induced apoptosis and depletion
of dopamine terminal markers in the striatum of mice. Brain Res.,
2005, 1049, 171-181.
Franklin, K.B.J., Paxinos, G. The Mouse Brain in Stereotaxic
Coordinates. The Academic Press: New York, 1997.
Zhu, J.P.Q., Xu, W., Angulo, J.A. Methamphetamine-induced cell
death: Selective vulnerability in neuronal subpopulations of the
striatum in mice. Neuroscience, 2006, 140, 607-622.
Bowyer, J.F., Robinson, B., Ali, S.F., Schmued, L.C. Neurotoxicrelated changes in tyrosine hydroxylase, microglia, myelin, and
blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Synapse, 2008, 62, 193-204.
Chang, L., Alicata, D., Ernst, T., Volkow, N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction, 2007, 102, 16-32.
Oh, J.S., Lyoo, I.K., Sung, Y.H., Hwang, J., Kim, J., Chung, A.,
Park, K.S., Kim, S.J., Renshaw, P.F., Song, I.C. Shape changes of
the corpus callosum in abstinent methamphetamine users. Neurosci.
Lett., 2005, 384, 76-81.

Revised: April 17, 2010

Accepted: May 26, 2010

